Ameritas Investment Partners, Inc. Mustang Bio, Inc. Transaction History

Ameritas Investment Partners, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.58 - $1.13 $2,467 - $4,808	-4,255 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$2.66 - $4.18 $7,009 - $11,014	2,635 Added 162.65%	4,255 $16,000
Q2 2018 Aug 13, 2018	BUY	$6.68 - $11.0 $10,821 - $17,820	1,620 New	1,620 $11,000

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $20M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.